Zacks Research Has Positive Forecast for CRSP Q2 Earnings
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities researchers at Zacks Research upped their Q2 2025 earnings estimates for CRISPR Therapeutics in a report issued on Tuesday, March 4th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of ($1.61) for the quarter, up from their prior forecast […]
CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) – Equities researchers at Zacks Research upped their Q2 2025 earnings estimates for CRISPR Therapeutics in a report issued on Tuesday, March 4th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of ($1.61) for the quarter, up from their prior forecast […]
